Shanghai Argo Biopharmaceutical Co., Ltd.
Shanghai Argo Biopharmaceutical Co., Ltd.
Explore linked clinical trials.8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants | Healthy Participants Study | Active, not recruiting | Phase 1 | 2026-09-23 | NCT07577479 | |
| Study of BW-50218 in Healthy Participants | Healthy Participants Study | Active, not recruiting | Phase 1 | 2026-09-03 | NCT07401472 | |
| A Phase 1 Clinical Study in Healthy Participants | HV | Recruiting | Phase 1 | 2026-07-09 | NCT07584876 | |
| A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants | HV | Not yet recruiting | Phase 1 | 2026-04-21 | NCT07528053 | |
| A Phase 2 in Adult Subjects With Hereditary Angioedema | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hereditary Complement Deficiency Diseases, Hypersensitivity, Immediate, Primary Immunodeficiency Diseases, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, hereditary angioedema, hereditary disease, immune system disorder, inborn error of immunity, skin disorder, skin vascular disease, urticaria, vascular disorder | Active, not recruiting | Phase 2 | 2026-04-17 | NCT06846398 | |
| A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 | 2026-01-15 | NCT07135349 | |
| A Study in Patients With Mixed Dyslipidemia | Mixed Dyslipidemia | Active, not recruiting | Phase 2 | 2026-01-13 | NCT06497127 | |
| A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy Volunteers | Healthy Volunteers Only | Recruiting | Phase 1 | 2025-07-25 | NCT06917482 |